Literature DB >> 33302383

Genomic Fabric Remodeling in Metastatic Clear Cell Renal Cell Carcinoma (ccRCC): A New Paradigm and Proposal for a Personalized Gene Therapy Approach.

Dumitru A Iacobas1, Victoria E Mgbemena2, Sanda Iacobas3, Kareena M Menezes4, Huichen Wang4, Premkumar B Saganti4,5.   

Abstract

Published transcriptomic data from surgically removed metastatic clear cell renal cell carcinoma samples were analyzed from the genomic fabric paradigm (GFP) perspective to identify the best targets for gene therapy. GFP considers the transcriptome as a multi-dimensional mathematical object constrained by a dynamic set of expression controls and correlations among genes. Every gene in the chest wall metastasis, two distinct cancer nodules, and the surrounding normal tissue of the right kidney was characterized by three independent measures: average expression level, relative expression variation, and expression correlation with each other gene. The analyses determined the cancer-induced regulation, control, and remodeling of the chemokine and vascular endothelial growth factor (VEGF) signaling, apoptosis, basal transcription factors, cell cycle, oxidative phosphorylation, renal cell carcinoma, and RNA polymerase pathways. Interestingly, the three cancer regions exhibited different transcriptomic organization, suggesting that the gene therapy should not be personalized only for every patient but also for each major cancer nodule. The gene hierarchy was established on the basis of gene commanding height, and the gene master regulators DAPK3,TASOR, FAM27C and ALG13 were identified in each profiled region. We delineated the molecular mechanisms by which TASOR overexpression and ALG13 silencing would selectively affect the cancer cells with little consequences for the normal cells.

Entities:  

Keywords:  ALG13; FAM27C; TASOR; VEGF signaling; VHL; basal transcription factors; cell cycle; chemokine signaling; genomic medicine; kidney cancer

Year:  2020        PMID: 33302383      PMCID: PMC7762545          DOI: 10.3390/cancers12123678

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  78 in total

1.  Organizational principles of the connexin-related brain transcriptome.

Authors:  David C Spray; Dumitru A Iacobas
Journal:  J Membr Biol       Date:  2007-07-27       Impact factor: 1.843

2.  The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.

Authors:  Christopher J Ricketts; Aguirre A De Cubas; Huihui Fan; Christof C Smith; Martin Lang; Ed Reznik; Reanne Bowlby; Ewan A Gibb; Rehan Akbani; Rameen Beroukhim; Donald P Bottaro; Toni K Choueiri; Richard A Gibbs; Andrew K Godwin; Scott Haake; A Ari Hakimi; Elizabeth P Henske; James J Hsieh; Thai H Ho; Rupa S Kanchi; Bhavani Krishnan; David J Kwiatkowski; Wembin Lui; Maria J Merino; Gordon B Mills; Jerome Myers; Michael L Nickerson; Victor E Reuter; Laura S Schmidt; C Simon Shelley; Hui Shen; Brian Shuch; Sabina Signoretti; Ramaprasad Srinivasan; Pheroze Tamboli; George Thomas; Benjamin G Vincent; Cathy D Vocke; David A Wheeler; Lixing Yang; William Y Kim; A Gordon Robertson; Paul T Spellman; W Kimryn Rathmell; W Marston Linehan
Journal:  Cell Rep       Date:  2018-06-19       Impact factor: 9.423

3.  Breast Cancer Suppression by Progesterone Receptors Is Mediated by Their Modulation of Estrogen Receptors and RNA Polymerase III.

Authors:  Jessica Finlay-Schultz; Austin E Gillen; Heather M Brechbuhl; Joshua J Ivie; Shawna B Matthews; Britta M Jacobsen; David L Bentley; Peter Kabos; Carol A Sartorius
Journal:  Cancer Res       Date:  2017-07-20       Impact factor: 12.701

Review 4.  Phospholipase A2 Isoforms as Novel Targets for Prevention and Treatment of Inflammatory and Oncologic Diseases.

Authors:  Nagendra Sastry Yarla; Anupam Bishayee; Lakshmipathi Vadlakonda; Ramakrishna Chintala; Govinda Rao Duddukuri; Pallu Reddanna; Kaladhar S V G K Dowluru
Journal:  Curr Drug Targets       Date:  2016       Impact factor: 3.465

Review 5.  Targeting the PI3K-Akt pathway in kidney cancer.

Authors:  Jin-Young Park; Pei-yin Lin; Robert H Weiss
Journal:  Expert Rev Anticancer Ther       Date:  2007-06       Impact factor: 4.512

6.  Expression of Genes Encoding for Xenobiotic Metabolism After Exposure to Dialkylnitrosamines in the Chicken Egg Genotoxicity Alternative Model.

Authors:  Tetyana Kobets; Michael J Iatropoulos; Jiandong D Duan; Klaus D Brunnemann; Dumitru A Iacobas; Sanda Iacobas; Esther Vock; Ulrich Deschl; Gary M Williams
Journal:  Toxicol Sci       Date:  2018-11-01       Impact factor: 4.849

7.  The Gene Master Regulators (GMR) Approach Provides Legitimate Targets for Personalized, Time-Sensitive Cancer Gene Therapy.

Authors:  Sanda Iacobas; Nneka Ede; Dumitru A Iacobas
Journal:  Genes (Basel)       Date:  2019-07-25       Impact factor: 4.096

8.  Tumour-Secreted Protein S (ProS1) Activates a Tyro3-Erk Signalling Axis and Protects Cancer Cells from Apoptosis.

Authors:  Nour Al Kafri; Sassan Hafizi
Journal:  Cancers (Basel)       Date:  2019-11-22       Impact factor: 6.639

Review 9.  Current Concepts of Non-Coding RNAs in the Pathogenesis of Non-Clear Cell Renal Cell Carcinoma.

Authors:  Dominik A Barth; Ondrej Slaby; Christiane Klec; Jaroslav Juracek; Rares Drula; George A Calin; Martin Pichler
Journal:  Cancers (Basel)       Date:  2019-10-17       Impact factor: 6.639

10.  Alteration of transcriptomic networks in adoptive-transfer experimental autoimmune encephalomyelitis.

Authors:  Dumitru A Iacobas; Sanda Iacobas; Peter Werner; Eliana Scemes; David C Spray
Journal:  Front Integr Neurosci       Date:  2007-12-30
View more
  2 in total

1.  Personalized 3-Gene Panel for Prostate Cancer Target Therapy.

Authors:  Sanda Iacobas; Dumitru Andrei Iacobas
Journal:  Curr Issues Mol Biol       Date:  2022-01-15       Impact factor: 2.976

2.  Theory and Applications of the (Cardio) Genomic Fabric Approach to Post-Ischemic and Hypoxia-Induced Heart Failure.

Authors:  Dumitru Andrei Iacobas; Lei Xi
Journal:  J Pers Med       Date:  2022-07-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.